Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient ...
A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...
Phenomix's MyPhenome test continues to demonstrate predictive accuracy in identifying which patients are most likely to respond to GLP-1 therapies such as semaglutide. Studies presented at Obesity ...
Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...
Medications for obesity may improve fertility, but there are many unknowns when it comes to using them during pregnancy.
For now, GLP-1 drugs remain a powerful tool for diabetes and obesity, with the potential to become much more. As research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results